Louis Lacasse
General Partner
Canada
20 investmentsLouis Lacasse is a General Partner based in Canada. Louis Lacasse has backed 20 companies, including Salmedix Inc, MethylGene and Copernicus Therapeutics. Investment focus areas include Health Care, Biotech and Medical Device.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (20)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Salmedix Inc | — | — | — | — |
| 2 | MethylGene | — | — | — | — |
| 3 | Copernicus Therapeutics | — | — | — | — |
| 4 | Cytochroma | — | — | — | — |
| 5 | NewBiotics | — | — | — | — |
| 6 | Ceptyr | — | — | — | — |
| 7 | Elitra Pharmaceuticals | — | — | — | — |
| 8 | Novalon Pharmaceutical | — | — | — | — |
| 9 | Message Pharmaceuticals | — | — | — | — |
| 10 | LymphoSign | — | — | — | — |
| 11 | GeneFormatics | — | — | — | — |
| 12 | Gene Logic | — | — | — | — |
Showing 1–12 of 20
Page 1 of 2
Access Full Contact Information
Get Louis Lacasse's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.